BiotechTubeBiotechTube
Home/Alligator Bioscience AB/Erik Magnusson
EM

Erik Magnusson

Chief Financial Officer

Alligator Bioscience AB

Therapeutic Areas

OncologyImmuno-oncology

Alligator Bioscience AB Pipeline

DrugIndicationPhase
Mitazalimab (ADC-1013)1st line metastatic pancreatic ductal adenocarcinoma (PDAC)Phase 2
Mitazalimab + chemotherapy1st line metastatic pancreatic ductal adenocarcinoma (PDAC)Phase 1b/2
ATOR-1017Advanced solid malignanciesPhase 1
ATOR-1015Advanced solid malignanciesPhase 1
ATORG-5Undisclosed solid tumorsPreclinical

Leadership Team at Alligator Bioscience AB

SB
Søren Bregenholt
Chief Executive Officer
JA
Jenny Ask Wallberg
Chief Scientific Officer
PN
Per Norlén
Chief Medical Officer
AB
Anders Björkelund
Vice President, Discovery
MB
Marcus Buggert
Chairman of the Board
PB
Peter Benson
Board Member
LH
Lars Hedbys
Board Member
AE
Annika Espander Jansson
Board Member
LÖ
Lars Öhrström
Board Member
LS
Lena Söderström
Board Member
View full Alligator Bioscience AB profile